Oncology

Does The Reformed Cancer Drug Fund Generate Evidence On Effectiveness? A Cross-sectional Analysis On Publicly Accessible Documentation.
Helen Poppy Macdonald, Ben Goldacre

medRxiv 2020.03.06.19014944; doi: https://doi.org/10.1101/2020.03.06.19014944
High dose-rate brachytherapy of localized prostate cancer converts tumors from cold to hot.
Simon Paul Keam, Heloise halse, Thu Nguyen, Minyu Wang, Nicolas Van Kooten Losio, Catherine Mitchell, Franco Caramia, David J Byrne, Sue Haupt, Georgina Ryland, Phillip K Darcy, Shahneen Sandhu, Piers Blombery, Ygal Haupt, Scott G Williams, Paul J Neeson

medRxiv 2020.03.02.20030346; doi: https://doi.org/10.1101/2020.03.02.20030346
Circulating tumor cell characterization of lung cancer brain metastasis in the cerebrospinal fluid through single-cell transcriptome analysis
Haoyu Ruan, Yihang Zhou, Jie Shen, Yue Zhai, Ying Xu, Linyu Pi, RuoFan Huang, Kun Chen, Xiangyu Li, Weizhe Ma, Zhiyuan Wu, Xuan Deng, Xu Wang, Chao Zhang, Ming Guan

medRxiv 2020.01.06.20016683; doi: https://doi.org/10.1101/2020.01.06.20016683
Upregulation of Human Endogenous Retrovirus-K (HML-2) mRNAs in hepatoblastoma: Identification of potential new immunotherapeutic targets and biomarkers
David F Grabski, Aakrosh Ratan, Laurie R. Gray, Stefan Bekiranov, David Rekosh, Marie-Louise A Hammmarskjold, Sara K Rasmussen

medRxiv 2020.02.28.20026260; doi: https://doi.org/10.1101/2020.02.28.20026260
Tumor-infiltrating immune cells signature predicts recurrence free survival after complete resection of localized primary gastrointestinal stromal tumors
Mengshi Yi, Rui Zhao, Qianyi Wan, Xiaoting Wu, Wen Zhuang, Han Shuo Yang, Chuncheng Wu, Lin Xia, Yi Chen, Yong Zhou

medRxiv 2020.02.28.20025908; doi: https://doi.org/10.1101/2020.02.28.20025908
Changes of the Commensal Microbiome during Treatment are Associated with Clinical Response in Nasopharyngeal Carcinoma Patients
Tingting Huang, Justine W Debelius, Alexander Ploner, Xiling Xiao, Tingting Zhang, Kai Hu, Zhe Zhang, Rensheng Wang, Weimin Ye

medRxiv 2020.02.27.20028647; doi: https://doi.org/10.1101/2020.02.27.20028647
Predicting the effect of statins on cancer risk using genetic variants: a Mendelian randomization study in UK Biobank
Paul Carter, Mathew Vithayathil, Siddhartha Kar, Rahul Potluri, Amy M Mason, Susanna C Larsson, Stephen Burgess

medRxiv 2020.02.28.20028902; doi: https://doi.org/10.1101/2020.02.28.20028902
Optimal Stereotactic Body Radiotherapy Dosage For Hepatocellular Carcinoma
Ting-Shi Su, Ying Zhou, Yong Huang, Ping Liang, Tao Cheng, Shi-Xiong Liang, Le-Qun Li

medRxiv 2020.02.27.20028621; doi: https://doi.org/10.1101/2020.02.27.20028621
SARS-CoV-2 transmission in cancer patients of a tertiary hospital in Wuhan
Jing Yu, Wen Ouyang, Melvin L.K. Chua, Conghua Xie

medRxiv 2020.02.22.20025320; doi: https://doi.org/10.1101/2020.02.22.20025320
A novel germline EGFR variant p.R831H causes predisposition to familial CDK12-mutant prostate cancer with tandem duplicator phenotype
Kaiyu Qian, Gang Wang, Lingao Ju, Jiyan Liu, Hang Zheng, Yingao Zhang, Liang Chen, Yaoyi Xiong, Yongwen Luo, Yejinpeng Wang, Tianchen Peng, Fangjin Chen, Dongmei Liu, Xuefeng Liu, Yi Zhang, Yu Xiao, Xinghuan Wang

medRxiv 2020.02.23.20027045; doi: https://doi.org/10.1101/2020.02.23.20027045

Oncology

Pages